Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Azamosadat Mousavi"'
Autor:
Azamosadat Mousavi, Nasim Eshraghi, Setareh Akhavan, Shahrzad Sheikhhasani, Narges Zamani, Zahra Valian, Aghdas Ebadi Jamkhane
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Introduction Ovarian granulosa cell tumor (OGCT) is a rare female pathology with few available demographic data. Besides, there are no comprehensive clinical characteristics regarding the OGCT in Iran. Thus, this study aimed to assess the cl
Externí odkaz:
https://doaj.org/article/6cfd90f5f8eb412d83e7865fd18c9ee7
Autor:
Azamosadat Mousavi, Azadeh Yousefnezhad, Mitra Modarres-Gilani, Setareh Akhavan, Shahrzad Sheikh-Hasani
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 8, Iss 4, Pp 1465-1469 (2019)
Background: We did not have any data about vulvar cancer — as a fourth cause of gynecological cancer in the worldwide — in our country. Study Design: Our study is designed to evaluate the frequency, stage and outcome of patients with vulvar cance
Externí odkaz:
https://doaj.org/article/ff95ce2d69de4502b42b304391fe6adb
Autor:
SetareNasiri, Shahrzad Sheikh Hasani, Azamosadat Mousavi, Mitra Modarres Gilani, SetareAkhavan, Mohammad Rahim Vakili
Publikováno v:
Iranian Journal of Medical Sciences, Vol 43, Iss 4, Pp 426-431 (2018)
Choriocarcinoma and placental site trophoblastic tumor (PSTT) are rare varieties of gestational trophoblastic disease (GTD). PSTT alone constitutes about 1-2% of all trophoblastic tumors, which presents at early reproductive age and the serum beta-hC
Externí odkaz:
https://doaj.org/article/74f1ed6e196c420e91497018e6023642
Autor:
Setareh Akhavan, Yalda Jefrideh, Azamosadat Mousavi, Mitra Modares-Gilani, Shahrzad Sheikh-Hasani
Publikováno v:
International Journal of Women's Health and Reproduction Sciences. 10:161-165
Objectives: Although ovarian cancer is the sixth most common cancer among women, in most cases, it is not diagnosed until it covers the entire peritoneum. In the present study, it was examined the clinical outcomes of the women with epithelial ovaria
Autor:
Fahimeh Nokhostin, Setareh Akhavan, Azamosadat Mousavi, Sahrzad Sheikh Hasani, Mitra Modarres Gilani
Publikováno v:
International Journal of Women's Health and Reproduction Sciences. 8:153-157
Objectives: The present study attempted to provide a clear view of gestational trophoblastic neoplasia (GTN) with the focus on resistance to treatment approaches in Iran. Materials and Methods: This retrospective cohort study reviewed the medical rec
Autor:
Mitra Modarres Gilani, Setare Akhavan, Fateme Saboctacin, Setare Nassiri, Azamosadat Mousavi, Shahrzad Sheikh Hassani
Publikováno v:
Indian Journal of Gynecologic Oncology. 15:49-53
Ovarian cancer is the most common cause of death among gynecologic malignancies around the world, and there are numerous criteria in preoperative differentiation between benign and malignant ovarian mass. The interaction between cancer and platelets
Autor:
Shahrzad Sheikhhasani, Mitra Modarres-Gilani, Azamosadat Mousavi, Azadeh Yousefnezhad, Setareh Akhavan
Publikováno v:
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care, Vol 8, Iss 4, Pp 1465-1469 (2019)
Journal of Family Medicine and Primary Care, Vol 8, Iss 4, Pp 1465-1469 (2019)
Background: We did not have any data about vulvar cancer — as a fourth cause of gynecological cancer in the worldwide — in our country. Study Design: Our study is designed to evaluate the frequency, stage and outcome of patients with vulvar cance
Autor:
Mitra Modarres, Azamosadat Mousavi, Zahra Golshani, Setare Nasiri, Shahrzad Sheikh Hassani, Setare Akhavan
Publikováno v:
Women's Health. 6
Autor:
Monire Mirzaei, Setare Nasiri, Setare Akhavan, Shahrzad Sheikh Hasani, Mohammad Rahim Rahim Vakili, Mitra Modarres Gilani, Azamosadat Mousavi
Publikováno v:
Journal of Obstetrics, Gynecology and Cancer Research. 2
Autor:
Setare Nasiri, Shahrzad Sheikh Hasani, Mitra Modarres Gilani, Setare Akhavan, Mohammad Rahim Rahim Vakili, Azamosadat Mousavi
Publikováno v:
Journal of Obstetrics, Gynecology and Cancer Research. 1